Ohtuvayre's rapid US launch boosts Verona's growth with Q1 2025 sales up 95%. Read more on VRNA stock's blockbuster potential ...

Bristol Myers Squibb outperformed the broader market in the latest session with a 1.22% gain, even as it faces financial ...